Joshua Keith Meisner, MD

Joshua Keith Meisner, MD, PhD

Specialty: Pediatric Cardiology
Title: Assistant Professor

To request an appointment call

734-764-5176
Joshua Keith Meisner, MD
Joshua Keith Meisner, MD, PhD
Pediatric Cardiology
  • About
  • Areas of Practice
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Research Overview
  • Manage Your Profile

  • About

    Dr. Meisner is a board-certified pediatric cardiologist and physician scientist. His clinical focus is on cardiovascular genetics, and he provides the pediatric cardiology services in the multidisciplinary hypertrophic cardiomyopathy, muscular dystrophy, cardiovascular genetics and aortopathy, and RASopathy clinics. He also sees general cardiology and molecular and biochemical cardiology patients in his individual clinics. His translational research laboratory utilizes induced pluripotent stem cell cardiomyocyte and innovative mouse models to understand the pathophysiology and clinical course that leads to cardiomyopathy in children and young adults.

    Areas of Practice

    pediatric cardiology, congenital heart disease, hypertrophic cardiomyopathy, muscular dystrophy, metabolic cardiomyopathy

    Locations

    • Congenital Heart Center | Brighton Center for Specialty Care 7500 Challis Rd
      Entrance 1, Level 2
      Brighton, MI 48116-9416
      Get Directions
    • Congenital Heart Center | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 11 Reception C
      Ann Arbor, MI 48109-4284
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    University of Michigan Medical School, 2015

    Residency

    University of Michigan Health System, Pediatrics, 2018

    Fellowships

    University of Michigan Health System, Pediatric Cardiology, 2021

    Board Certifications

    Pediatric Cardiology
    Pediatrics

    Research Overview

    Hypertrophic cardiomyopathy, precision therapeutics for genetic cardiomyopathies, RASopathies, TANGO2 deficiency disorder